ConductScience.org, home

Paper36964229

Structural requirement of RARγ agonism through computational aspects.

Liu H and 9 others. J Mol Model, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Structural requirement of RARγ agonism through computational aspects. Papers, record 36964229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structural requirement of RARγ agonism through computational aspects.
PubMed
Journal
J Mol Model
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2026-10-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHaihan
2Hu BBaichun
3Luan JJiasi
4Sun YYuqing
5Wang SShizun
6Li WWeixai
7Chen LLu
8Wang HHanxun
9Gao YYinli
10Wang JJian

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Molecular Dynamics SimulationMajor topic
Quantitative Structure-Activity RelationshipMajor topic
Molecular Docking Simulation

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Grant No. D20029Overseas Expertise Introduction Project for Discipline InnovationPubMed
2012520005Program for Innovative Talents of Higher Education of LiaoningPubMed

Source PubMed

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131452096Integrating Molecular Docking and Molecular Dynamics Simulations.Methods Mol Biol2019https://conductscience.org/library/papers/31452096PubMed
233652835Trifarotene: A Current Review and Perspectives in Dermatology.Biomedicines2021https://conductscience.org/library/papers/33652835PubMed
334339839Nuclear receptors in liver fibrosis.Biochim Biophys Acta Mol Basis Dis2021https://conductscience.org/library/papers/34339839PubMed
420543827A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.Nat Struct Mol Biol2010https://conductscience.org/library/papers/20543827PubMed
515027865Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.J Med Chem2004https://conductscience.org/library/papers/15027865PubMed
632100454Selective RAR agonists for acne vulgaris: A narrative review.J Cosmet Dermatol2020https://conductscience.org/library/papers/32100454PubMed
725933005An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.PLoS One2015https://conductscience.org/library/papers/25933005PubMed
831255985Role of Retinoic Acid Receptor-γ in DNA Damage-Induced Necroptosis.iScience2019https://conductscience.org/library/papers/31255985PubMed
935178333Binding free energy of protein/ligand complexes calculated using dissociation Parallel Cascade Selection Molecular Dynamics and Markov state model.Biophys Physicobiol2021https://conductscience.org/library/papers/35178333PubMed
1030802558Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.J Am Acad Dermatol2019https://conductscience.org/library/papers/30802558PubMed
1112220491C-H...O hydrogen bonds in the nuclear receptor RARgamma--a potential tool for drug selectivity.Structure2002https://conductscience.org/library/papers/12220491PubMed
1233472949Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells.Mol Cancer Res2021https://conductscience.org/library/papers/33472949PubMed
1310964567Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.J Mol Biol2000https://conductscience.org/library/papers/10964567PubMed
1432854112A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.Blood2021https://conductscience.org/library/papers/32854112PubMed
1529706423Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.Bioorg Med Chem Lett2018https://conductscience.org/library/papers/29706423PubMed
1624962887Complexity of the RAR-mediated transcriptional regulatory programs.Subcell Biochem2014https://conductscience.org/library/papers/24962887PubMed
1731694317Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.Cells2019https://conductscience.org/library/papers/31694317PubMed
1823579614Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.J Comput Aided Mol Des2013https://conductscience.org/library/papers/23579614PubMed
197501014Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.Nature1995https://conductscience.org/library/papers/7501014PubMed
2010841540Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARgamma.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10841540PubMed

See all 28 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42625115Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids.Clin Transl Oncol2026https://conductscience.org/library/papers/42625115PubMed
41641227A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds.Health Sci Rep2026https://conductscience.org/library/papers/41641227PubMed
38927935P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis.Cancers (Basel)2024https://conductscience.org/library/papers/38927935PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RARG5916PubTator's text mininghttps://conductscience.org/library/genes/5916

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36964229

GET https://conductscience.org/api/papers/v1/36964229/references?page=2